Immunsuppression bei membranöser Glomerulonephritis – Pro

Schlüsselwörter

membranöse Glomerulonephritis - Immunsuppression

Keywords

membranous nephropathy - immunosuppression

Literatur

• 1 Beck L H, Bonegio R G, Lambeau G. et al . M-type phosholipase A2 receptor as target antigen in idiopathic membranous nephropathy.  N Engl J Med. 2009;  361 11-21
• 2 Bomback A S, Derebail V K, McGregor J G. et al . Rituximab therapy for membranous nephropathy: A systematic review.  CJASN. 2009;  4 734-744
• 3 Cattran D. Management of membranous nephropathy: When and what for treatment?.  JASN. 2005;  16 1188-1194
• 4 Debiec H, Guigonis V, Mougenot B. et al . Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.  N Engl J Med. 2002;  346 2053-2060
• 5 Kerjaschki D. Pathomechanisms and molecular basis of membranous glomerulonephritis.  Lancet. 2004;  364 1194-1196